DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Ubicación actual:
> This Story

Conexión o Registro to rate this News Story
Forward Printable StoryPrint Comment



Artificial Intelligence Homepage

Digital Surgery launches first real-time AI surgical system for OR New approach may help increase qualified surgeons, global access to care

Not enough imaging data to train AI on rare pathologies? Create it! Researchers use machine learning to produce realistic artificial X-rays

Guerbet and IBM Watson to develop AI-based liver diagnostics solution Supports liver diagnostics in CT and MR

KT Corporation and Russian Railways launch Russian digital health system Assist providers in all 173 Russian Railway stations

The pulse of medical AI: An innovation prognosis Assessing the overall challenges and progress being made

Google leverages raw EMR data and AI to predict risk of death May lower healthcare costs and false alerts

U.S. Healthcare not in good health and ready for innovation Digital technology presents the opportunity to tame rising healthcare costs

MIT researchers develop AI tool for registering medical images in minutes Acquires information on alignment and parameter estimating while registering scans

Artificial intelligence’s role in incubating new healthcare solutions Although still in its infancy, momentum is building

Non-traditional EHR tech companies vying for stake in market Google, Microsoft, Apple and Amazon among top companies

A China-based AI system proved to be
more accurate in detecting brain cancer
and hematomas than human physicians

AI wins against human diagnosis of brain tumors and hematomas

por John R. Fischer , Staff Reporter
The potential for machine learning-based diagnoses continues to gain wider acceptance worldwide with its latest accomplishment revolving around the diagnosis of brain cancer and internal bleeding.

The BioMind AI System, designed by Beijing Tiantan Hospital and Capital Medical University, went two for two in late June, in a competition among groups of physicians to accurately predict the presence of brain tumors and hematoma expansion.

Story Continues Below Advertisement

RaySafe helps you avoid unnecessary radiation

RaySafe solutions are designed to minimize the need for user interaction, bringing unprecedented simplicity & usability to the X-ray room. We're committed to establishing a radiation safety culture wherever technicians & medical staff encounter radiation.

"I hope through this competition, doctors can experience the power of artificial intelligence,” Wang Yongjun, executive vice president of the Beijing Tiantan Hospital, said in a statement. “This is especially so for some doctors who are skeptical about artificial intelligence.”

Though impressed by the capabilities presented by AI and machine learning, many physicians have expressed fears that such technology will grow in their potential to a point where it eventually replaces human doctors.

Trained on tens of thousands of images of nervous system-related diseases archived by the hospital over the past 10 years, the BioMind AI System is capable of predicting common neurological conditions such as meningioma and gliomas with a 90 percent accuracy rate comparable to that of a senior doctor.

In predicting the presence of brain tumors, the solution was 87 percent accuracy rate in its assessment of 225 cases, completing its determinations in 15 minutes. A team of 15 senior physicians, in comparison, was 66 percent accurate.

The system was then used to assess cases of brain hematoma expansion, correctly diagnosing its presence with 83 percent accuracy compared to 63 percent obtained by a group of physicians from renowned hospitals throughout China.

Outcomes made by the human physicians were considered normal and better than the average accuracy of those at ordinary hospitals.

Yongjun says the results of the competition fall in line with its main objective to serve as a learning experience for clinicians regarding their interaction with technology, and further support the adoption of AI, not as a replacement, but as an assistant.

“I hope they can further understand AI and eliminate their fears toward it,” he said.

Adoption of AI is slated to provide value to medical imaging in a variety of areas including scheduling and administration; patient management; pre-scanning; in-scanning; post-scanning; and predictive analytics.

All cases assessed in the competition were real and contributed by Beijing Tiantan Hospital, but were not used as training material for the solution.

The system was developed jointly by the hospital’s Artificial Intelligence Research Centre for Neurological Disorders and a research team from Capital Medical University.

Artificial Intelligence Homepage

You Must Be Logged In To Post A Comment

Aumente su conciencia de marca
Subastas + ventas Privadas
Consigue el mejor precio
Comprar Equipo/Piezas
Encuentra El Precio Más Bajo
Noticias diarias
Lee las últimas noticias
Examina todos los usuarios DOTmed
Ética en DOTmed
Ver nuestro programa de ética
El oro parte programa del vendedor
Recibir las solicitudes de PH
Programa de distribuidor con servicio gold
Recibe solicitudes
Proveedores de atención de salud
Ver todos los HCP (abreviatura de asistencia médica) Herramientas
Encontrar/rellenar un trabajo
Parts Hunter +EasyPay
Obtener presupuestos para piezas
Certificado recientemente
Ver usuarios certificados recientemente
Recientemente clasificado
Ver usuarios certificados recientemente
Central de alquiler
Alquila equipos por menos
Vende equipos/piezas
Obtén más dinero
Mantenga el foro de los técnicos
Buscar ayuda y asesoramiento
Petición sencilla de propuestas
Obtén presupuestos para equipos
Feria comercial virtual
Encuentra servicio para el equipo
El acceso y el uso de este sitio está conforme a los términos y a las condiciones de nuestro AVISO LEGAL & AVISO DE LA AISLAMIENTO
Característica de y propietario DOTmeda .com, inc. Copyright ©2001-2018, Inc.